S&P 500   3,557.09 (-0.01%)
DOW   29,382.35 (+0.41%)
QQQ   288.54 (-0.63%)
AAPL   114.17 (-2.70%)
MSFT   208.46 (-0.92%)
FB   265.04 (-1.73%)
GOOGL   1,715.98 (-1.17%)
AMZN   3,076.81 (-0.73%)
TSLA   518.23 (+5.85%)
NVDA   521.70 (-0.35%)
BABA   270.51 (-0.08%)
CGC   24.31 (+2.49%)
GE   10.19 (+4.41%)
MU   63.74 (+3.81%)
AMD   85.90 (+1.49%)
T   28.53 (+0.74%)
NIO   52.55 (+6.70%)
F   8.85 (+1.26%)
ACB   7.11 (-0.28%)
GILD   59.59 (-0.87%)
NFLX   482.74 (-1.13%)
BA   207.71 (+4.05%)
DIS   141.78 (+0.50%)
S&P 500   3,557.09 (-0.01%)
DOW   29,382.35 (+0.41%)
QQQ   288.54 (-0.63%)
AAPL   114.17 (-2.70%)
MSFT   208.46 (-0.92%)
FB   265.04 (-1.73%)
GOOGL   1,715.98 (-1.17%)
AMZN   3,076.81 (-0.73%)
TSLA   518.23 (+5.85%)
NVDA   521.70 (-0.35%)
BABA   270.51 (-0.08%)
CGC   24.31 (+2.49%)
GE   10.19 (+4.41%)
MU   63.74 (+3.81%)
AMD   85.90 (+1.49%)
T   28.53 (+0.74%)
NIO   52.55 (+6.70%)
F   8.85 (+1.26%)
ACB   7.11 (-0.28%)
GILD   59.59 (-0.87%)
NFLX   482.74 (-1.13%)
BA   207.71 (+4.05%)
DIS   141.78 (+0.50%)
S&P 500   3,557.09 (-0.01%)
DOW   29,382.35 (+0.41%)
QQQ   288.54 (-0.63%)
AAPL   114.17 (-2.70%)
MSFT   208.46 (-0.92%)
FB   265.04 (-1.73%)
GOOGL   1,715.98 (-1.17%)
AMZN   3,076.81 (-0.73%)
TSLA   518.23 (+5.85%)
NVDA   521.70 (-0.35%)
BABA   270.51 (-0.08%)
CGC   24.31 (+2.49%)
GE   10.19 (+4.41%)
MU   63.74 (+3.81%)
AMD   85.90 (+1.49%)
T   28.53 (+0.74%)
NIO   52.55 (+6.70%)
F   8.85 (+1.26%)
ACB   7.11 (-0.28%)
GILD   59.59 (-0.87%)
NFLX   482.74 (-1.13%)
BA   207.71 (+4.05%)
DIS   141.78 (+0.50%)
S&P 500   3,557.09 (-0.01%)
DOW   29,382.35 (+0.41%)
QQQ   288.54 (-0.63%)
AAPL   114.17 (-2.70%)
MSFT   208.46 (-0.92%)
FB   265.04 (-1.73%)
GOOGL   1,715.98 (-1.17%)
AMZN   3,076.81 (-0.73%)
TSLA   518.23 (+5.85%)
NVDA   521.70 (-0.35%)
BABA   270.51 (-0.08%)
CGC   24.31 (+2.49%)
GE   10.19 (+4.41%)
MU   63.74 (+3.81%)
AMD   85.90 (+1.49%)
T   28.53 (+0.74%)
NIO   52.55 (+6.70%)
F   8.85 (+1.26%)
ACB   7.11 (-0.28%)
GILD   59.59 (-0.87%)
NFLX   482.74 (-1.13%)
BA   207.71 (+4.05%)
DIS   141.78 (+0.50%)
Log in
NYSE:HRC

Hill-Rom Stock Forecast, Price & News

$97.77
+0.28 (+0.29 %)
(As of 11/23/2020 11:33 AM ET)
Add
Compare
Today's Range
$97.02
Now: $97.77
$98.47
50-Day Range
$82.10
MA: $90.64
$97.00
52-Week Range
$72.29
Now: $97.77
$117.68
Volume11,232 shs
Average Volume641,020 shs
Market Capitalization$6.53 billion
P/E Ratio31.54
Dividend Yield0.90%
Beta0.62
Hill-Rom Holdings, Inc. operates as a medical technology company worldwide. It operates in Patient Support Systems, Front Line Care, and Surgical Solutions segments. The company offers medical surgical beds, intensive care unit beds, and bariatric patient beds, lifts and other devices, non-invasive therapeutic products and surfaces, and information technologies and software solutions, as well as sells equipment service contracts for its capital equipment. It also provides patient monitoring and diagnostics products, such as patient exam and diagnostics, patient monitoring, diagnostic cardiology, vision screening, and diagnostics products; and respiratory health products comprising Vest System, VitalCough System, MetaNeb System, Monarch, and Life2000 systems to assist patients in the mobilization of retained blockages. In addition, the company offers surgical solutions that include surgical tables, lights, and pendants; positioning devices for use in shoulder, hip, spinal, and lithotomy surgeries, as well as platform-neutral positioning accessories for operating room tables. Further, it is involved in the sales and rental of products to acute and extended care facilities through direct sales force and distributors; sales and rental of products directly to patients in the home; and sales to primary care facilities through distributors. Additionally, the company offers continuum of clinical care, including acute care and primary care, as well as clinical research organizations. Hill-Rom Holdings, Inc. was founded in 1969 and is headquartered in Chicago, Illinois.
Read More
Hill-Rom logo

Beat the Market (BTM) Rank

Analyst Opinion: 3.4Community Rank: 2.5Dividend Strength: 1.7Insider Behavior: 1.7Valuation: 0.0 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

1.85 out of 5 stars


Industry, Sector and Symbol

Industry Surgical & medical instruments
Sub-IndustryHealth Care Equipment
SectorMedical
CUSIP43147510
Phone312-819-7200
Employees10,000

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$2.91 billion
Cash Flow$9.11 per share
Book Value$23.55 per share

Profitability

Net Income$152.20 million

Miscellaneous

Market Cap$6.53 billion
Next Earnings Date1/22/2021 (Estimated)
OptionableOptionable
$97.77
+0.28 (+0.29 %)
(As of 11/23/2020 11:33 AM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive HRC News and Ratings via Email

Sign-up to receive the latest news and ratings for HRC and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles











Hill-Rom (NYSE:HRC) Frequently Asked Questions

How has Hill-Rom's stock price been impacted by COVID-19?

Hill-Rom's stock was trading at $89.15 on March 11th, 2020 when COVID-19 reached pandemic status according to the World Health Organization (WHO). Since then, HRC stock has increased by 10.0% and is now trading at $98.04.
View which stocks have been most impacted by COVID-19
.

Do Wall Street analysts recommend investors buy shares of Hill-Rom?

7 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Hill-Rom in the last year. There are currently 1 hold rating and 6 buy ratings for the stock, resulting in a consensus recommendation of "Buy."
View analyst ratings for Hill-Rom
.

What stocks does MarketBeat like better than Hill-Rom?

Wall Street analysts have given Hill-Rom a "Buy" rating, but there may be better short-term opportunities in the market. Some of MarketBeat's winning trading ideas this year have resulted in 5-15% weekly gains. MarketBeat just released five new trading ideas, but Hill-Rom wasn't one of them. MarketBeat thinks these five stocks may be even better buys.
View MarketBeat's top stock picks here.

When is Hill-Rom's next earnings date?

Hill-Rom is scheduled to release its next quarterly earnings announcement on Friday, January 22nd 2021.
View our earnings forecast for Hill-Rom
.

How were Hill-Rom's earnings last quarter?

Hill-Rom Holdings, Inc. (NYSE:HRC) announced its quarterly earnings results on Friday, November, 6th. The medical technology company reported $1.17 EPS for the quarter, topping the Thomson Reuters' consensus estimate of $1.07 by $0.10. The medical technology company had revenue of $705.30 million for the quarter, compared to analysts' expectations of $696.36 million. Hill-Rom had a return on equity of 25.48% and a net margin of 7.05%. The company's revenue was down 9.9% on a year-over-year basis. During the same quarter in the prior year, the firm earned $1.69 EPS.
View Hill-Rom's earnings history
.

How often does Hill-Rom pay dividends? What is the dividend yield for Hill-Rom?

Hill-Rom announced a quarterly dividend on Wednesday, November 4th. Shareholders of record on Wednesday, December 16th will be given a dividend of $0.22 per share on Thursday, December 31st. This represents a $0.88 annualized dividend and a dividend yield of 0.90%. The ex-dividend date is Tuesday, December 15th.
View Hill-Rom's dividend history
.

What guidance has Hill-Rom issued on next quarter's earnings?

Hill-Rom issued an update on its FY21 earnings guidance on Friday, November, 6th. The company provided earnings per share guidance of $5.25-5.45 for the period, compared to the Thomson Reuters consensus estimate of $5.38.

What price target have analysts set for HRC?

7 analysts have issued 1 year target prices for Hill-Rom's stock. Their forecasts range from $107.00 to $125.00. On average, they expect Hill-Rom's share price to reach $116.29 in the next year. This suggests a possible upside of 18.6% from the stock's current price.
View analysts' price targets for Hill-Rom
.

Are investors shorting Hill-Rom?

Hill-Rom saw a drop in short interest in the month of October. As of October 15th, there was short interest totaling 1,170,000 shares, a drop of 14.0% from the September 30th total of 1,360,000 shares. Based on an average daily trading volume, of 581,900 shares, the short-interest ratio is presently 2.0 days. Approximately 1.8% of the company's stock are short sold.
View Hill-Rom's Short Interest
.

Who are some of Hill-Rom's key competitors?

What other stocks do shareholders of Hill-Rom own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Hill-Rom investors own include Steel Dynamics (STLD), The Walt Disney (DIS), NVIDIA (NVDA), Square (SQ), PayPal (PYPL), salesforce.com (CRM), CVS Health (CVS), Micron Technology (MU), AbbVie (ABBV) and Bank of America (BAC).

Who are Hill-Rom's key executives?

Hill-Rom's management team includes the following people:
  • Mr. John P. Groetelaars, Pres, CEO & Director (Age 53, Pay $2.23M)
  • Ms. Barbara W. Bodem, Sr. VP & CFO (Age 52, Pay $1.13M)
  • Ms. Deborah M. Rasin, Sr. VP, Chief Legal Officer & Sec. (Age 53, Pay $906.56k)
  • Mr. Andreas G. Frank, Sr. VP & Pres of Front Line Care business (Age 44, Pay $1.12M)
  • Mr. Paul S. Johnson, Sr. VP & Pres of Patient Support Systems (Age 55, Pay $981.63k)
  • Mr. Timothy P. Lawrence, Sr. VP of Operations (Age 57)
  • Mr. Richard M. Wagner, VP, Controller & CAO (Age 52)
  • Mr. Brian Lawrence, CTO & Sr. VP (Age 50)
  • Ms. Sue-Jean Lin, Chief Information Officer & Sr. VP
  • Ms. Mary Kay Ladone, Sr. VP of Corp. Devel., Strategy & Investor Relations (Age 45)

What is Hill-Rom's stock symbol?

Hill-Rom trades on the New York Stock Exchange (NYSE) under the ticker symbol "HRC."

Who are Hill-Rom's major shareholders?

Hill-Rom's stock is owned by many different institutional and retail investors. Top institutional investors include BlackRock Inc. (9.26%), Victory Capital Management Inc. (3.93%), State Street Corp (2.41%), UBS Asset Management Americas Inc. (1.79%), Cooke & Bieler LP (1.72%) and LSV Asset Management (1.29%). Company insiders that own Hill-Rom stock include Amy M Dodrill, Andreas G Frank, Deborah Rasin, Mary Kay Ladone and Paul Sherwood Johnson.
View institutional ownership trends for Hill-Rom
.

Which institutional investors are selling Hill-Rom stock?

HRC stock was sold by a variety of institutional investors in the last quarter, including Jennison Associates LLC, BlackRock Inc., Neuberger Berman Group LLC, Allianz Asset Management GmbH, First Trust Advisors LP, Dana Investment Advisors Inc., Charles Schwab Investment Management Inc., and State Street Corp. Company insiders that have sold Hill-Rom company stock in the last year include Amy M Dodrill, Andreas G Frank, Mary Kay Ladone, and Paul Sherwood Johnson.
View insider buying and selling activity for Hill-Rom
.

Which institutional investors are buying Hill-Rom stock?

HRC stock was acquired by a variety of institutional investors in the last quarter, including LSV Asset Management, Victory Capital Management Inc., UBS Asset Management Americas Inc., Wells Fargo & Company MN, Arrowstreet Capital Limited Partnership, AQR Capital Management LLC, Boston Trust Walden Corp, and Principal Financial Group Inc..
View insider buying and selling activity for Hill-Rom
.

How do I buy shares of Hill-Rom?

Shares of HRC can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is Hill-Rom's stock price today?

One share of HRC stock can currently be purchased for approximately $98.04.

How big of a company is Hill-Rom?

Hill-Rom has a market capitalization of $6.55 billion and generates $2.91 billion in revenue each year. The medical technology company earns $152.20 million in net income (profit) each year or $5.08 on an earnings per share basis. Hill-Rom employs 10,000 workers across the globe.

What is Hill-Rom's official website?

The official website for Hill-Rom is www.hill-rom.com.

How can I contact Hill-Rom?

Hill-Rom's mailing address is 130 East Randolph Street Suite 1000, Chicago IL, 60601. The medical technology company can be reached via phone at 312-819-7200 or via email at [email protected]

This page was last updated on 11/23/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.